Myriad Genetics Inc. expanded its partnership with Intermountain Precision Genomics to add a new liquid biopsy therapy selection test to its oncology portfolio.
Aadi Bioscience Inc. has received a product-specific, permanent J-code for Fyarro (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for intravenous use for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).
The National Cancer Institute approved the following clinical research studies last month. Â
FDA has announced proposed product standards that would prohibit menthol as a characterizing flavor in cigarettes and prohibit all characterizing flavors other than tobacco in cigars.
MD Anderson, Community Health Network announce partnership to create fully integrated cancer program
The University of Texas MD Anderson Cancer Center and Indianapolis-based Community Health Network announced a partnership agreement to create Community Health Network MD Anderson Cancer Center.Â
Shelley Johns was named the Walther Scholar in Psycho-Oncology at Indiana University School of Medicine.Â
UC Davis Comprehensive Cancer Center is launching the Center for Advancing Cancer Health Equity, which will conduct community-engaged research and interventions.
The American Cancer Society and St. Baldrick’s Foundation recently awarded $1.2 million in a second round of Pilot Accelerator grants requiring researchers to use clinical trials to accelerate treatment options for childhood cancer.Â
The American Society for Transplantation and Cellular Therapy presented awards to researchers in the field of transplantation and cellular therapy at the tandem meetings of ASTCT and the Center for International Blood and Marrow Transplant Research.
Independence Blue Cross and the Colorectal Cancer Alliance announced a cancer screening and prevention program which aims to address the decrease in colorectal cancer screening rates among Black Philadelphians since the pandemic started.Â
